Loss of DNA methyltransferase activity in primed human ES cells triggers increased cell-cell variability and transcriptional repression by Tsankov, A. et al.
STEM CELLS AND REGENERATION RESEARCH ARTICLE
Loss of DNA methyltransferase activity in primed human ES cells
triggers increased cell-cell variability and transcriptional
repression
Alexander M. Tsankov1,2,*,§, Marc H. Wadsworth, II2,3,4,*, Veronika Akopian5, Jocelyn Charlton5,6,
Samuel J. Allon2,3,4, Aleksandra Arczewska5,6, Benjamin E. Mead2,3,4, Riley S. Drake2,3,4, Zachary D. Smith5,
Tarjei S. Mikkelsen7, Alex K. Shalek2,3,4,‡,§ and Alexander Meissner2,5,6,‡,§
ABSTRACT
Maintenance of pluripotency and specification towards a new cell fate
are both dependent on precise interactions between extrinsic signals
and transcriptional and epigenetic regulators. Directed methylation of
cytosines by the de novo methyltransferases DNMT3A and DNMT3B
plays an important role in facilitating proper differentiation, whereas
DNMT1 is essential for maintaining global methylation levels in all cell
types. Here, we generated single-cell mRNA expression data from
wild-type, DNMT3A, DNMT3A/3B and DNMT1 knockout human
embryonic stem cells and observed a widespread increase in cellular
and transcriptional variability, even with limited changes in global
methylation levels in the de novo knockouts. Furthermore, we found
unexpected transcriptional repression upon either loss of the de
novomethyltransferase DNMT3A or the double knockout of DNMT3A/
3B that is further propagated upon differentiation to mesoderm and
ectoderm. Taken together, our single-cell RNA-sequencing data
provide a high-resolution view into the consequences of depleting the
three catalytically active DNMTs in human pluripotent stem cells.
KEY WORDS: DNA methylation, DNA methyltransferases,
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INTRODUCTION
Isogenic populations of cells can exhibit substantial phenotypic
variation, which can, in turn, play an important role in development
and in adapting to changing external conditions (Heitzler and
Simpson, 1991). Variation in gene expression, due to stochastic
bursting and asymmetric division of key molecular drivers of cellular
identity, accounts for a large amount of observed cell-to-cell (cell-
cell) variability within a given cell type (McAdams andArkin, 1997).
Cellular heterogeneity has historically been measured using
microscopy and fluorescent labeling of key markers. These
techniques have high spatial and cellular resolution but rely on
prior knowledge and a limited number of markers, making it difficult
to assay cellular differences comprehensively. The advent of single-
cell genomic methods now enables profiling of transcriptional,
genetic and epigenetic variation between individual cells on a global
scale that depends less on a priori hierarchies and predefined markers
(Tanay and Regev, 2017).
Single-cell RNA-sequencing (scRNA-seq), in particular, has led to
remarkable advances in defining and refining the myriad cell states
(Shalek et al., 2013, 2014), cell types (Jaitin et al., 2014; Shekhar et al.,
2016; Montoro et al., 2018) and progenitors (Treutlein et al., 2014;
Olsson et al., 2016) that are present during mammalian development
and differentiation (Petropoulos et al., 2016; Tang et al., 2010;
Scialdone et al., 2016; Klein et al., 2015). This has been aided by
computational advances in clustering and pseudotemporal ordering of
single cells that have enabled accurate inference of cell states and
developmental trajectories, respectively (Trapnell et al., 2014;
Haghverdi et al., 2015; Street et al., 2018). From a biological
perspective, scRNA-seq has allowed the role of transcriptional
heterogeneity to be explored. For example, single-cell profiling of
mouse embryonic stem (ES) cells has revealed sporadic expression of
polycomb targeted lineage regulators and less heterogeneity among
pluripotency-associated genes in 2i versus serum growth conditions
(Kumar et al., 2014). These results suggest a model whereby mouse
ES cells are afforded the opportunity to access lineage specification
programs through stochastic expression of pluripotency factors and
lineage regulators typically repressed by H3K27me3.
DNA methylation also plays an important role in maintenance of
and exit frompluripotency. Variation inDNAmethylationmodulates
metastable switching inmouse ES cells between ZFP42 low and high
states (Singer et al., 2014). Three catalytically active DNA
methyltransferases (DNMTs) are responsible for maintenance
(DNMT1) and de novo DNA methylation (DNMT3A/3B) in
mammals, and all three are essential for normal development
(Smith and Meissner, 2013). DNA methylation by DNMT3A/3B
plays a particularly important role during development and ES cell
differentiation (Gifford et al., 2013; Ziller et al., 2018), and both
catalytically active enzymes are highly expressed in undifferentiated
cells. Bulk experiments have shown a limited global impact of
DNMT3A/3B knockout on the global DNA methylation landscape
in human ES cells (Liao et al., 2015). This limited effect may be, in
part, a consequence of bulk measurements, and it remains unknown
how these epigenetic regulators affect transcriptional variation at the
single-cell level, including how this may bias differentiation to new
cell fates. To study this, we utilized previously generated knockoutReceived 7 December 2018; Accepted 12 August 2019
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cell lines (Liao et al., 2015) in the undifferentiated and differentiated
states to investigate the effects of these mutations on transcription at
single-cell resolution.
RESULTS
Increased cellular variation in ES cells lacking DNMT3A
and DNMT3A/3B
To explore the role of DNMTs in transcriptional regulation within
individual cells, we used Smart-Seq2-based scRNA-seq (Picelli et al.,
2014) to profile three HUES64 human ES cell lines –wild type (WT),
with homozygous catalytic disruption ofDNMT3A (3AKO), andwith
double knockout of both DNMT3A/3B (DKO) (Liao et al., 2015).
Although the global decrease in methylation levels in the DKO cells is
limited (Fig. 1A), they have 10-fold more differentially methylated
regions than 3AKO relative to WT (Liao et al., 2015). Dimensionality
reduction showed that WT, 3AKO and DKO cells mostly cluster by
cell line (Fig. 1B). We found that 3AKO and DKO undifferentiated
cells were equally dissimilar toWT ES cells (Fig. 1C, top), which was
unexpected given themuch greater similarity in the global methylation
landscape between WT and 3AKO bulk samples (Liao et al., 2015).
Interestingly, we noticed a significantly higher intra-sample cell-cell
distance in the DKO and 3AKO populations relative to WT (P<10−15,
Wilcoxon signed rank test, Fig. 1C, bottom).
To control for the effect of background differentiation on our
measure of cellular heterogeneity, we classified all cells as pluripotent,
endoderm (dEN), mesoderm (dME) and ectoderm (dEC) using
previously reported germ layer markers (Gifford et al., 2013; Tsankov
et al., 2015a,b). We observed an increase in differentiated cells in
DNMT mutant cells and a distinct bias towards ectoderm in 3AKO
cells (Fig. 1D). We then in silico sorted for all undifferentiated cells
and found that the intra-sample cell-cell distance using only cells
classified as pluripotent was also significantly higher in themutant cell
lines relative to WT (P<10−15, Wilcoxon signed rank test, Fig. S1A).
Our results were unchanged when repeating this analysis using three
different cell-cell distance metrics (Euclidean, Manhattan, Spearman
correlation; see Materials and Methods) and after controlling for data
quality by focusing the analysis on the highest-quality ES cells
(Fig. S1B,C). Among undifferentiated 3AKO and DKO cells, we also
found increased variation in pluripotency, ectoderm and endoderm
scores (Fig. 1E). Taken together, these results suggest increased cell-
cell transcriptional variation that may affect the differentiation
potential in 3AKO and DKO cells.
DNA methylation and transcript variation in DNMT3A/3B
knockouts
To further examine whether disruption of the de novo
methyltransferases also increases global transcriptional variability,
we computed the dispersion – log(variance/mean) – and standard
deviation in expression for every gene within each sample
population (Fig. 2A, Fig. S2A left). DKO and 3AKO showed a
significant increase in transcript variation at all genes relative to WT
using both metrics (P<10−15, Wilcoxon signed rank test; Fig. 2A)
that associated with a corresponding decrease in mean promoter
methylation level (Fig. 2B). To control for the impact of technical
dropouts on our measurements of transcript variation, we explicitly
modeled three parameters for the expression of each gene: the
fraction of cells with no detectable expression (α), and the mean (μ)
and standard deviation (σ) of expression among only detectably
expressing cells (McDavid et al., 2013 and Shalek et al., 2014). As
an example, the transcriptional variation of CTCFL increased in
DKO versus WT cells as measured both by dispersion and by σ,
whereas α decreased (Fig. 2C). As observed using dispersion, we
also confirmed a global increase in transcriptional variation using σ
in the DNMT mutants relative to WT cells (Fig. S2A, right).
Globally, we found that difference in dispersion was highly
correlated with difference in σ (r=0.75) but not with difference in
α (r=−0.04, Fig. 2D), indicating that changes in the fraction of cells
with detectable expression between samples does not associate with
the global increase in transcriptional variation we report among
DNMT mutant and WT ES cells. Consistent with the increased
variation in pluripotency scores (Fig. 1E), we also observed a
significant increase in standard deviation of expression across all
cells and cells with detectable expression (σ) at pluripotency gene
markers (P<10−6, Wilcoxon signed rank test, Fig. S2A), indicating
that DNMT disruption leads to more variable expression of key
pluripotency genes. We further quantified the relationship between
Fig. 1. Increased cellular variation inDNMT3A andDNMT3A/3B knockout ES cells. (A) Violin plot of CpGmethylation for wild-type (WT),DNMT3A−/− (3AKO)
and DNMT3A/3B−/− (DKO) cells averaged across two replicates. Mean methylation level and number of CpGs per sample are shown at the bottom and black
boxes within the violin plots represent the interquartile range. Data were obtained from Liao et al. (2015) and are available at GEO under accession number
GSE63281. (B) Dimensionality reduction ofWT, 3AKO and DKO single ES cells (dots) using t-distributed stochastic neighbor embedding (t-SNE) and hierarchical
clustering (bottom right) of the averaged expression profiles for sorted ES cells from each cell line. Samples 3AKO and DKOwere more similar to each other than
toWT ES cells. (C) Inter-sample (top) and intra-sample (bottom) density distribution of all pairwise cell-cell distances for WT, 3AKO and DKO cells. (D) Fraction of
WT, 3AKO and DKO cells classified into four categories: ES cell; endoderm (dEN); mesoderm (dME); and ectoderm (dEC). (E) Violin plots of ES cell, dEN, dME
and dEC scores for WT, 3AKO and DKO samples: each dot represents an in silico-sorted undifferentiated cell.
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changes in dispersion and average expression. We found 4740 and
1139 genes with a higher dispersion (difference greater than 1.5) in
the DNMT mutants and WT cells, respectively; of those, 92% and
97%, respectively, also displayed a higher mean expression in the
sample with higher dispersion (Fig. S2B). We confirmed the trends
in transcriptional variation that we observed in the scRNA-seq
data from WT and 3AKO cells for ZFP42, MAP4K4 and RAD51
using RNA fluorescence in situ hybridization (FISH; Fig. 2E,F,
Fig. S2C). The standard deviation of gene expression for ZFP42
using RNA FISH was slightly higher in WT versus 3AKO, whereas
the difference in transcriptional variation was more pronounced
between the two conditions for MAP4K4 and RAD51. In summary,
we find increased transcriptional variation in undifferentiated 3AKO
and DKO cells at genes that predominantly increase in mean
expression; however, this increase in transcript variation is
uncorrelated with dropout rate in our scRNA-seq data.
Changes in DNA methylation variability have been linked to
cancer risk markers, higher order chromatin organization and
variability in gene expression across cancer patients (Hansen et al.,
2011; Jenkinson et al., 2017; Teschendorff and Widschwendter,
2012). DNAmethylation variability can be measured in phase at the
individual read level using bisulfite sequencing, whereby each read
can be considered to derive from a different cell. Globally, an
increase in the percentage of reads displaying discordant
methylation states was reported for DKO, but not for 3AKO,
relative to WT ES cells (Liao et al., 2015). In addition, we measured
the normalizedmethylation entropy (NME) (Jenkinson et al., 2017),
an alternative approach based on statistical physics and information
theory, and found that NME increased slightly in 3AKO and
drastically in DKO relative to WT as mean methylation level
decreased (Fig. 2G). Density scatter plots showed that the increase
in NME was largely due to a shift of high methylation level CpGs
with low entropy in WT to intermediate methylation level CpGs
with high entropy in DKO (Fig. 2H). As the DKO-specific increase
in NME does not appear to be proportional to the increase in
transcriptional variation observed in both 3AKO and DKO, it
suggests that genome-wide DNA methylation variability does not
fully explain global transcript variation.
To further explore the relationship between DNA methylation
and transcriptional dispersion at a single-cell level, we focused our
analysis on gene promoters. We initially performed promoter
epigenetic state enrichment analysis in ES cells (Gifford et al., 2013)
for the most and least transcriptionally variable genes inWT, 3AKO
and DKO samples, and found an association between low
dispersion genes and H3K9me3-enriched or highly methylated
promoters in WT cells (Fig. S2D). In contrast, whereas genes with
Fig. 2. Relationship betweenDNAmethylation level, meanmethylation entropy and transcript variation inDNMT3A andDNMT3A/3B knockouts. (A) Box
plots of gene expression dispersion distribution, log(variance/mean), for all genes, ES cell markers and WT low dispersion genes for WT, 3AKO and DKO
ES cells. (B) Violin plots of promoter mean CpG methylation for all genes, ES cell markers and WT low dispersion genes from WT, 3AKO and DKO ES cell bulk
samples, averaged across two replicates. Dots represent the mean and lines extend at most one standard deviation from the mean. (C) Histograms of CTCFL
expression in WT (top) and DKO (bottom) cells binned at intervals of 0.5 log(TPM+1) expression levels and normalized to the total cell counts. The three
parameters that are estimated for CTCFL gene expression distribution (α, μ and σ) are shown in blue, orange and green, respectively. Dispersion for CTCFL
increases and coincides with an increase in σ and μ as well as a decrease in α. (D) Scatter plots of the difference in dispersion, log(variance/mean) and
parameters σ (left) and α (right) in DKO versus WT cells. We observe a high correlation between dispersion and σ difference (r=0.75) but not between dispersion
and α difference (r=−0.04). (E) Left: representative images of RNA FISH with probes targeting ZFP42 (red) in WT (left) and 3AKO (right) ES cells. Cell
segmentation is shown using white outlines. Scale bars: 10 μm. Right: box plots of ZFP42 (left), MAP4K4 (middle) and RAD51 (right) integrated probe intensity
summed over the volume of the cell for WT, 3AKO and unstained (Unst.) ES cells. (F) Violin plots of log(TPM+1) gene expression for ZFP42 (left), MAP4K4
(middle) and RAD51 (right) in WT and 3AKO ES cell scRNA-seq data show similar trends in transcript variation as the RNA FISH experiment for these three
genes. (G) Normalized methylation entropy (NME; left) and mean methylation level (MML; right) measured using WT, 3AKO and DKO ES cell whole genome
bisulfite sequencing data across all chromosome 21 and 22 CpGs using the approach in Jenkinson et al. (2017). (H) Smoothed scatter plot with color intensity
showing density of all chromosome 21 and 22 CpGs NME versus MML data. For WT, most CpGs have high MML and low NME (dark blue, bottom right). DKO
CpGs with high NME spread across a lower MML (middle top of DKO plot; intensity gets darker), consistent with the global loss of methylation in the DKO sample.
Box plots: boxes display the interquartile range, horizontal line within the box shows the median, whiskers extend to the most extreme data point that is no more
than 1.5 times the length of the interquartile range.
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H3K9me3-enriched promoters also correlated with genes of lowest
transcriptional variance in 3AKO and DKO cells, high methylation
promoters showed low to no correlation (Fig. S2D). Consistent with
this result, for the least variable genes in WT ES cells, we found a
significant increase in mean expression and transcriptional
dispersion in 3AKO and DKO samples (P<10−15, Wilcoxon
signed rank test; Fig. 2A, right) and a concomitant decrease in
DNA methylation at the corresponding promoters (Fig. 2B). This
implies that the expression of low dispersion genes in WT is
regulated, in part, by the DNA methylation level. Although mean
methylation and transcript dispersion levels appear to correlate at
these genes, the same correlation is not apparent when comparing
promoter mean NME and transcriptional variation globally, as
measured by gene dispersion or σ (Fig. S2E,F). Together, this
suggests that the increase in transcript variability observed after loss
of DNMT3A/3B associates with loss of methylation at a subset of
promoters but not globally.
Widespread transcriptional repression and super-enhancer
misregulation
To better understand the regulatory changes that underlie the observed
transcriptional dynamics in the DNMT3A/3B mutants, we identified
all three-way differentially expressed genes between WT, 3AKO and
DKO sorted samples (Fig. 3A). We found that the vast majority of
genes were repressed (1964) rather than activated (470) relative toWT,
which was somewhat unexpected given that loss of methylation is
typically more associated with gene activation. Among the most
downregulated genes in human ES cells, we observed a number of
zinc fingers and important pluripotency transcription factors (TFs),
including ZFP42, PRDM14, NANOG, POU5F1 and MYC
(Table S1). Interestingly, the latter three TFs showed lower
expression in 3AKO than DKO despite the DKO being generated
through a DNMT3B deletion in the DNMT3A knockouts (Liao et al.,
2015). We also found a number of housekeeping genes with reduced
expression, including those encoding actin, heterogeneous nuclear
ribonucleoproteins (HNRNPs) and proteasome genes.
We next performed a comprehensive search for promoter
enrichment against published DNA methylation, histone
modification and TF binding data from matched samples (Fig. 3B)
to explore the potential underlying mechanism (Gifford et al., 2013;
Tsankov et al., 2015b; Liao et al., 2015). We found a significant
association between loss of promoter methylation and expression
increase, as illustrated at the CTCFL locus (Fig. 3C, top). Surprisingly,
we also identified 152 and 82 promoters that increased in DNA
Fig. 3. Global transcriptional repression and altered regulation in DNMT3A and DNMT3A/3B knockout ES cells. (A) Differentially expressed genes (right;
rows) for sorted populations ofWT, 3AKO andDKOES cells (columns). Genes are separated into six gene sets [left: 100 (n=1443), 101 (n=191), 110 (n=330), 011
(n=229), 010 (n=143) and 001 (n=98)], where 1 or 0 indicates high or low expression for the respective condition (order: WT, 3AKO, DKO). (B) Genomic
enrichment analysis for gene sets (columns) defined in panel A against CpG density features, epigenetic and TF binding data collected in matching WT ES cells
(Gifford et al., 2013; Tsankov et al., 2015b). (C) Top: distribution (dots indicate individual cells) of CTCFL expression (left) and the corresponding CpGmethylation
levels at the CTCFL locus for WT, 3AKO and DKO ES cells. Bottom: ZFP42 cellular expression (left) and promoter methylation (right) as described above.
(D) Of all 684 H1 ES cell super-enhancers (Hnisz et al., 2013), 321 (47%) are located within 1 kb of a DKO DMR (displayed in black). In total, 734 DKO DMRs (of
44,244 total) were associated with super-enhancers, and are defined as regions with difference in methylation>0.6 relative to WT, with P<0.01 (F-test).
(E) Functional enrichment analysis for the gene sets defined in panel A against the REACTOME database. (F) Distribution of cell cycle phase-specific expression
for sorted WT, 3AKO and DKO ES cells considering all genes, cell cycle annotated genes and differentially expressed cell cycle annotated genes. Error bars
indicate one standard deviation. DMR, differentially methylated region; K, lysine on histone 3; me3, tri-methylation; ac, acetylation; me1, mono-methylation.
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methylation (e.g. ZFP42; Fig. 3C, bottom) in 3AKO and DKO,
respectively, which overlapped significantlywith decreased expression
in the mutants (Fig. 3B). Genes repressed in the knockouts frequently
had high CpG-dense promoters that were enriched for active histone
modification in WT cells (H3K27ac and, to a lesser degree,
H3K4me3 and H3K4me1; Fig. 3B). DNMT3A and DNMT3B
have previously been shown to occupy active enhancers, and
knockdowns of the de novo methyltransferases reduced super-
enhancer activity and disrupted homeostasis in epidermal stem cells
(Rinaldi et al., 2016). In our dataset, repressed genes (e.g. NANOG,
POU5F1) associated significantly with upstream H3K27ac and
H3K4me1 super-enhancers, suggesting a similar role for the de novo
methyltransferases at super-enhancers in human ES cells. We also
found that nearly half of human ES cell super-enhancers (Hnisz et al.,
2013) showed drastic changes in methylation levels in DKO (Fig. 3D,
Fig. S3A), suggesting that DNMT3A/3B shape the methylation
landscape near super-enhancers. We further identified high
enrichment for in vivo binding of a number of key pluripotency
associated TFs upstream of 3AKO and DKO repressed genes,
including MYC, NANOG, and POU5F1. As these factors occupy
76% of downregulated gene promoters in WT ES cells, a large
fraction of the repressed phenotype may be mediated by their
decreased expression and/or activity in the mutants. Taken together,
loss of DNMT3A and DNMT3A/3B appears to interfere with normal
super-enhancer activity upstream of pluripotency associated
regulators, leading to downregulation of these core ES cell TFs and
their downstream targets.
Loss of DNMT3A/3B alters cell cycle gene expression
Wenext performedgene set enrichment analysis andobserved that genes
upregulated in the 3AKO and DKO mutants included those encoding a
number of ribosomal proteins (e.g. RPL13/31) that are associated with
the influenza life cycle and viral RNA transcription and replication
(Fig. 3E, bottom). Combined with the observation that ERVH48-1 and
ERVH-1 are also upregulated in the DKO, these changes in expression
point to increased activity of endogenous retroviral elements.
Interestingly, we also found that downregulated genes associated with
a number of cell cycle categories, including gene sets related to G1/S
transition and the establishment of checkpoints (Fig. 3E, top).
To investigate possible cell cycle alterations in the DNMT3A/3B
mutants, we identified all differentially expressed cell cycle annotated
genes in the WT, 3AKO and DKO ES cell samples (Fig. S3B). We
found decreased expression relative to WT ES cells in a number of
key cell cycle genes (e.g. TP53, MCM2/3/4/5/6 and ORC1/2/5, Fig.
S3B) that were also downregulated during normal differentiation
(Gifford et al., 2013). We also observed downregulation of CDK4/6
and upregulation of CCND1 in the 3AKO,which has previously been
observed during normal ectoderm differentiation (Gifford et al.,
2013). Although the proportion of cells in different phases of the cell
cycle is similar for all three samples (Fig. S3C), we found a global
shift from constant to phase-specific cell cycle expression in the
DNMT3A/3B mutants at all genes and, especially, at ones annotated
to have cell cycle function (Fig. 3F). Taken together, our data show a
global change in expression of cell cycle-associated genes upon
DNMT3A/3B loss with increases in phase-specific cell cycle
expression that suggest the establishment of a regulated G1/S
transition and cell cycle checkpoints relative to WT human ES cells.
Aberrant expression following ES cell differentiation
of DNMT3A/3B knockouts
To investigate whether and how the observed transcriptional
changes in the knockouts affect cellular specification, we
differentiated all three cell lines for 5 days towards dME and dEC
followed by scRNA-seq. Dimensionality reduction showed that
cells clustered primarily by cell type and sample identity (Fig. 4A).
We observed a similar proportion of dME- and dEC-positive cells
between knockout and WT samples following differentiation
(Fig. 4B). The spread of dEC scores was similar across WT, 3AKO
andDKOdEC samples, whereas variation in dME scores was slightly
greater in the 3AKO dME sample relative to WT and DKO
(Fig. S4A). Population averaged transcriptomes for all samples
clustered by cell type (Fig. 4C) and showed that dEC samples were
more similar to ES cells than dME samples, which is consistent with
the inherent dEC bias we noted in 3AKO and DKO ES cells (Fig. 1D,
E). In line with our ES cell results, we found that the DKO dME/dEC
cells were slightly more similar to WT dME/dEC than 3AKO dME/
dEC cells (Fig. 4D, left). We also observed an increase in intra-
sample cell distance in the knockouts versus WT for both dME and
dEC (Fig. 4D, right), although the difference was not as pronounced
as in ES cells (Fig. 1C).
We then identified all differentially expressed genes in WT,
3AKO and DKO dME and dEC samples and compared them with
the ES cell populations.We found that in dME 36% and in dEC 34%
of differentially expressed genes had a similar change in expression
in the ES cell mutants, including 59% in dME and 42% in dEC of
the genes repressed in both ES cell knockouts (Fig. 4E). These
genes included ZFP42 (Fig. S4B), actin family genes and
proteasome genes (Fig. 4F,G, gene set 100.1), and associated with
some of the same functional categories as repressed genes in the ES
cell knockouts (e.g. protein metabolism, immune system, apoptosis;
Fig. 4H). In dME, a number of genes associated with extracellular
matrix organization and collagen formation (BMP1, COL4A1/2/6)
were downregulated uniquely in dMEDNMTmutants and not in ES
cells (Fig. 4H, gene set 100.0). We saw a similar enrichment for
translation and viral response for upregulated genes in both ES cell
and dME knockouts versus WT (Fig. 4H, gene set 011.1, e.g.
RPS19/27/28), and enrichment for mRNA processing and splicing
pathways for dME-specific knockout activated genes (Fig. 4H, gene
set 011.0).
To investigate the underlying mechanisms that may explain the
transcriptional changes in the dME and dEC knockouts, we
overlapped the promoter epigenetic state with differentially
expressed gene categories. We found that genes that gain
methylation in the three germ layers are also upregulated in DKO
but not in 3AKO dME, suggesting that DNMT3B may compensate
for DNMT3A loss at these lineage-specific targets (Fig. S4C). This
trend was also notable in dEC but to a lesser degree (Fig. S4D).
Further, we observed enrichment of high-CpG promoters (HCP) and
CpG islands for inherited repressed genes (100.1) but not for dME- or
dEC-specific repressed genes (100.0). Finally, we found an
enrichment for genes downstream of super-enhancers being
misregulated in dEC knockouts relative to WT, including FGFR1
(gene set 101), SOX11 (011) andNR6A1 (010). In dME, we found an
association between dME upstream super-enhancers and dME-
specific gene repression (gene set 100.0), including COL4A1/2,
KRT8, CD99, and the TF HAND1, which may point to a cell type-
specific role of DNMT3A/3B at dME super-enhancers. Moreover,
downregulation of HAND1 may mediate further downstream
repression at its dME targets, as we observed for core TFs POU5F1
and NANOG in undifferentiated DNMT3A/3B knockouts.
We also found a number of TFs with important roles in
developmental processes and oncogenesis to be aberrantly expressed
in the dEC and dME DNMT mutants relative to WT. In dEC, genes
encoding keyTFs associatedwith ectoderm lineage developmentwere
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specifically downregulated in DKO (e.g. PAX3, NR2F1/2),
upregulated in both mutants (e.g. SOX11) or upregulated in 3AKO
relative to WT (e.g. SOX9, ZIC2, POU4F1, PAX7; Fig. S4E).
Moreover, key pluripotency TFs, such as POU5F1, with a promoter
that is focally methylated during differentiation, and PRDM1, along
with POU domain TFs POU5F2 and POU2F2, were specifically
upregulated in the DKO dEC sample relative to WT (Fig. S4E,
bottom). This was accompanied by an increase in the median and
standard deviation of ES cell scores observed in dEC DKO cells
versus WT (Fig. S4F). In dME, TFs MEIS1, PBX1, HOXB1 and
SOX4were upregulated in the 3AKO cells relative toWT (Fig. 4I). As
the promoter methylation of HOXB1 increases drastically during ES
cell differentiation towards dEN and dME, and this gain in dEN
depends on the catalytic activity of DNMT3A (Fig. 4J), it is likely that
theHOXB1 promoter methylation is misregulated in a similar manner
in dME cells lacking DNMT3A. Although we do not observe a
change in promoter methylation for the genes encoding TFs MEIS1
and SOX4, their expression is correlated with HOXB1 (r=0.2,
P value<0.05; Pearson) implying that these TFs are co-regulated as
part of the same gene expression program.
Fig. 4. Transcriptional changes and
misregulation in DNMT3A/3B knockout cells
during ES cell differentiation. (A) Dimensionality
reduction of wild-type (WT), DNMT3A knockout
(3AKO) and DNMT3A/3B knockout (DKO) single ES,
mesoderm (dME) and ectoderm (dEC) cells (dots)
using t-distributed stochastic neighbor embedding
(t-SNE). Number of cells is shown in parentheses.
(B) Fraction of WT, 3AKO and DKO mesoderm (left)
and ectoderm (right) cells classified into four cell
types (ES cell, dEN, dME, dEC). (C) Hierarchical
clustering of the averaged expression profiles for all
sorted samples. (D) Inter-sample (left) and intra-
sample (right) density distribution of all pairwise cell-
cell distances (1–Pearson correlation coefficient) for
WT, 3AKO and DKO dME (top) and dEC (bottom)
cells. (E) Fraction of differentially expressed genes in
dME (red) and dEC (blue) that were not already
present in ES cells, or are dME/dEC unique. Gene
sets are defined in the legend for F. (F) Differentially
expressed genes (right; rows) for sorted population of
WT, 3AKO and DKO ES and mesoderm cells
(columns). Genes are separated into eight gene sets
(left: 100.1, 100.0, 101, 110, 011.1, 011.0, 010 and
001), for which 1 or 0 indicates high or low
expression, respectively, for each condition (order:
dME WT, 3AKO, DKO). Suffix .1 indicates inherited
from ES cells whereas .0 indicates dME unique.
(G) Differentially expressed genes (right; rows) for
sorted population of WT, 3AKO and DKO ES and
ectoderm cells (columns). Genes are separated into
eight gene sets as described above. (H) Functional
enrichment analysis for the dME gene sets defined in
F against the REACTOME database. (I) Distribution
of gene expression, log(TPM+1), for selected TFs
aberrantly expressed in 3AKO and DKO dME cells,
relative to WT. Dots represent cells. (J) CpG
methylation levels at the HOXB1 locus for ES, dEN,
dME, 3AKO ES and 3AKO dEN cells. The HOXB1
promoter is highlighted with a gray bar and the mean
promoter methylation level is listed on the right.
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Finally, we observed aberrant expression for a number of cell cycle
annotated genes and key transcriptional regulators in the knockouts
after dME and dEC differentiation. In dME mutants, and especially in
3AKO, we observed downregulation of mitosis-associated genes
CDK1 and CCNA2 (Fig. S4G) as well as cell cycle-associated genes
linked to lineage choice (CCND1, CCND3, CDKN1A). In dEC
mutants, a number of S-phase genes were downregulated (MCM2/5/7)
as well as CCND1 (Fig. 4G), which acts to block endoderm formation
in late G1 phase (Pauklin and Vallier, 2013) and promotes
neuroectoderm cell fate (Pauklin et al., 2016). In both dME and
dEC,we observed a similar proportion of cells in different phases of the
cell cycle (Fig. S4H) and levels of phase-specific expression (Fig. S4I).
Loss of DNMT1 triggers increased transcript variation and
differentiation
To complement our results from the de novoDNAmethyltransferases,
we explored the effects of loss of the maintenance enzyme DNMT1.
Loss of DNMT1 results in a global loss of DNA methylation rather
than the limited dynamics we find in the DNMT3 knockouts (Liao
et al., 2015). Specifically, we utilized our previously established
doxycycline-inducible downregulation of DNMT1 system and
collected live cells every day for 8 days for single cell methylation
profiling and at day 0, 2 and 8 following doxycycline treatment for
scRNA-seq.We observed global loss of methylation in all the profiled
cells beginning at day 2, which plateaued at a minimum at around day
6 to 8 (Fig. 5A). Dimensionality reduction of the scRNA-seq revealed
a high similarity between most day 0 and day 2 cells, with a gradual
departure fromWT for some day 2 cells and all day 8 cells (Fig. 5B).
Quantifying cell type identity (Fig. 5C) showed an increase in cells
exiting pluripotency at day 8, with a preference of escape towards
ectoderm, as observed in 3AKO and DKO. We found that both the
population average similarity between in silico-sorted undifferentiated
samples (Fig. 5B, bottom right) and the inter-sample ES cell distance
versus day 0 (Fig. 5D, top) increased with time after doxycycline
induction. We also observed an increase in intra-sample cell-cell
distance at day 2 and day 8 compared with day 0 (Fig. 5D, bottom),
and note that the heterogeneity at day 8 exceeds that found in the
DNMT3A/3B knockout ES cells (Fig. 1C). Variation in gene
expression also increased at day 2 and day 8 for all genes,
pluripotent markers and the least variable WT genes (P<10−8,
Wilcoxon signed rank test; Fig. 5E). Our results were consistent after
controlling for differences in data quality and sequencing depth
between samples. We again found an association between genes with
the lowest expression dispersion and high methylation promoter
occupancy at day 0, and this enrichment gradually decreased at day 2
and day 8, with downregulation ofDNMT1 and concurrent global loss
of methylation (Fig. S5A), as we observed for 3AKO andDKO versus
WT ES cells.
To gain insight into the functional changes induced by
downregulation of DNMT1, we identified all differentially
expressed genes in ES cells collected at day 0, 2 and 8 (Fig. 5F).
The majority (1638 of 2631; 62%) of day 8 differentially expressed
genes were repressed relative to day 0, as observed in 3AKO and
DKO ES cells. We found downregulation as early as day 2 of a
number of ribosomal protein genes (e.g. RPS24/15, RPL12/19)
associated with influenza life cycle (Fig. 5G, gene set 100). At
day 8, we observed a small downregulation of POU5F1 and
other pluripotency-associated genes (e.g. CD24, DPPA4) and
concomitant activation of NODAL signaling genes, including
NODAL, CER1, LEFTY1/2 and downstream TF PITX2 (Yoshioka
Fig. 5. Increased transcript variation and differentiation upon loss of DNMT1. (A) Violin plot of single cell methylation data, where each dot represents the
averageCpGmethylation level per cell. Cells were collected for scRNA-seq after 0, 2 and 8 days of doxycycline treatment. (B) Dimensionality reduction of day 0, 2
and 8 single cells (dots) using t-distributed stochastic neighbor embedding (t-SNE) and hierarchical clustering (bottom right) of the averaged expression
profiles for in silico-sorted ES cell populations. (C) Fraction of cells classified into four categories (ES cell, dEN, dME, dEC) following 0, 2 and 8 days of doxycycline
treatment. (D) Inter-sample (top) and intra-sample (bottom) density distribution of all pairwise cell-cell distances for in silico-sorted ES cells at day 0, 2 and 8.
(E) Box plots of gene expression dispersion distribution at all genes, ES cell markers, and WT low dispersion genes for sorted ES cell populations at day 0,
2 and 8. (F) Differentially expressed genes (right; rows) for sorted population of ES cells at day 0, 2 and 8 (columns). Genes are separated into six gene sets
[left: 100 (n=337), 101 (n=36), 110 (n=1301), 011 (n=349), 010 (n=139) and 001 (n=644)], where 1 or 0 indicates high or low expression for the respective
condition (day 0, 2 and 8). (G) Functional enrichment analysis for the gene sets defined in F against the REACTOME database.
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et al., 1998). We also note a shift in expression from glycolysis
genes (e.g. GAPDH, PFKP/M) at day 0/2 to lipid metabolism at
day 2 (e.g. FABP3, FADS2), to oxidative phosphorylation genes
(MT-ND2, MT-ND4L) at day 8 (Fig. 5F,G). Finally, we observed
changes in cell cycle regulation for ES cells that survived loss of
methylation, including an increase in fraction of G2/M cells
(Fig. S5B) and increase in cell cycle phase-specific expression
(Fig. S5C). These changes might reflect a longer G2/M phase
needed for methylation maintenance fidelity and compacting of
chromosomes. Taken together, we observe repression at most
differentially expressed genes and an increase in differentiation, as
well as cellular and gene expression variation in ES cells upon loss
of DNMT1.
DISCUSSION
Pluripotent stem cells are a powerful model to explore the targets and
role of epigenetic regulators. We have previously generated knockout
human ES cell lines for the three catalytically active DNA
methyltransferases (Liao et al., 2015). With the advance of single-
cell technologies, wewanted to explore the effects of these knockouts
within individual cells to better understand how the subtle changes in
the undifferentiated state translate to substantial disruptions upon exit
from pluripotency (Ziller et al., 2018). Using our scRNA-seq
approach, we observed a global increase in cellular and gene
expression variation for all DNMT mutants. As variability has been
linked to the ability of a cell to evolve and adapt to a changing
environment (Heitzler and Simpson, 1991), our results suggest that
disruption of DNMTs may increase cellular plasticity. It would
therefore be interesting in the future to explore the effects of this by
tracking individual cells using molecular barcoding (Chan et al.,
2019).
We also found two somewhat unexpected effects in the double
knockout ES cells. First, we found widespread repression in gene
expression upon loss of DNMT3A and DNMT3A/3B in the
undifferentiated cells, particularly at genes associated with CpG
islands and with H3K27ac super-enhancers. In epidermal stem
cells, knockdown of the de novo methyltransferases triggers a
reduction of super-enhancer activity (Rinaldi et al., 2016) and this
may occur through a similar mechanism in human ES cells, albeit at
different loci. In support of our findings, in epidermal stem cells we
also observe 7765 genes that are downregulated versus 2136
upregulated (1.4 fold difference) in the DNMT3A knockdown
versus control (Rinaldi et al., 2016). Secondly, we do observe a gain
of DNA methylation at selected sites in the 3AKO and DKO ES
cells. As the latter are derived from the 3AKO this may be a
consequence of DNMT3B activity. Known DNMT3B targets
include germline genes and it will be interesting to explore how
and why these additional loci are targeted in the mutant ES cells.
Differentiation of 3AKO and DKO towards mesoderm and
ectoderm showed that the knockout repressed genes were largely
inherited from ES cells. We also observed that dME DNMT mutant
repressed genes associated with super-enhancers in a mesoderm-
specific manner. As core TFs (NANOG, POU5F1 in ES cells;
HAND1 in mesoderm) are associated with super-enhancers, we
provide evidence that DNMT3A/3B disruption may lead to
decreased expression of key cell identity TFs and their
downstream targets. Furthermore, we find upregulation of a
number of key developmental and oncogenic TFs in 3AKO
mesoderm (e.g. MEIS1/2, PBX1, HOXB1, SOX4) and 3AKO
ectoderm (SOX11, SOX9, ZIC2, POU4F1, PAX7). DNMT3A is
often mutated in human tumors (Kim et al., 2013), has been shown
to act as a first hit mutation (Shlush et al., 2014), and its loss in
hematopoietic stem cells and the epidermis promotes leukemia and
squamous cell carcinoma formation, respectively (Rinaldi et al.,
2017; Yang et al., 2016). It will be interesting in the future to further
explore the possible role of increased transcriptional variability in
tumor initiation and progression. Taken together, we show that
combining scRNA-seq and genetic perturbations presents a
powerful tool for dissecting the role of epigenetic regulators in
development and disease.
MATERIALS AND METHODS
Human ES cell culture
Cell culture was carried out as reported previously (Tsankov et al., 2015b).
Briefly, we chose the National Institutes of Health-approved, male human
ES cell line HUES64 because it has maintained a stable karyotype over
many passages and is able to differentiate well into mesoderm and
ectoderm. The cells are frequently tested for mycoplasma and identity for
the knockout cell lines was confirmed through genotyping PCR. ES cells
were maintained on ∼15,000 cells/cm2 irradiated murine embryonic
fibroblasts (MEFs, MTI-GlobalStem) and cultured in 20% KnockOut
Serum Replacement (KSR, Life Technologies), 200 mM Glutamax (Life
Technologies), 1× Minimal Essential Medium (MEM) Non-essential
Amino Acids Solution (Life Technologies), 10 μg/ml basic fibroblast
growth factor (bFGF, Millipore), 55 µM β-mercaptoethanol in Knockout
Dulbecco’s Modified Eagle Medium (KODMEM, Life Technologies). ES
cells were passaged every 4-5 days using 1 mg/ml Collagenase IV (Life
Technologies). All human ES cell work has been approved by the Harvard
University ESCRO (#E00021).
Directed differentiation of human ES cells towards mesoderm
and ectoderm
When human ES cells reached 60-70% confluency on MEFs, the cells were
plated as clumps on 6-well plates coated with Matrigel (Life Technologies)
in mTeSR1 basal medium (Stemcell Technologies). We maintained the cells
for 3 days in feeder-free culture and then induced directed differentiation
towards mesoderm and ectoderm. For the first 24 h of mesoderm
differentiation, cells were cultured in DMEM/F12 medium supplemented
with 100 ng/ml Activin A (R&D Systems), 10 ng/ml bFGF (Millipore),
100 ng/ml BMP4 (R&D Systems), 100 ng/ml VEGF (R&D Systems), 0.5%
fetal bovine serum (Hyclone), 200 mMGlutaMax (Life Technologies), 0.2×
MEMNon-essential Amino Acids Solution (Life Technologies) and 55 µM
β-mercaptoethanol. From 24 to 120 h of mesoderm differentiation, Activin
A was removed from the culture. To induce ectoderm differentiation, cells
were cultured for 5 days in DMEM/F12 differentiation media supplemented
with 2 µM TGFβ inhibitor (Tocris, A83-01), 2 µM WNT3A inhibitor
(Tocris, PNU-74654), 2 µM Dorsomorphin BMP inhibitor (Tocris), 55 µM
β-mercaptoethanol, 1× MEM Non-essential Amino Acids Solution (Life
Technologies) and 15% KOSR (Life Technologies). Media were changed
daily. Before inducing differentiation, we manually removed the
differentiated cell clumps.
Cell collection and fluorescence-activated cell sorting
Cells were treated with StemPro Accutase (Life Technologies, #A1110501)
for 5 min, quenched in MEF medium and pelleted using centrifugation
[5 min, 1000 rpm (94 g)]. Media was aspirated and cell pellets were washed
once in PBS. RNAwas immediately stabilized by resuspending the cells in
RNAprotect Cell Reagent (∼100 μl per 100,000 cells, Qiagen, #76526) and
1 μl of RNaseOUT Recombinant Ribonuclease Inhibitor (Life
Technologies, #10777-019). Before sorting, cells in RNAprotect Cell
Reagent were diluted in ∼1.5 ml PBS (pH 7.4; no calcium, no magnesium,
no phenol red; Life Technologies, #10010-049). Also, 5 μl of lysis buffer,
composed of a 1/500 dilution of Phusion HF buffer (New England Biolabs,
#B0518S) was aliquoted in Eppendorf 96-well skirted plates (VWR,
#95041-430). Cells were sorted individually in each well of 96-well plates
using the FACSAria II flow cytometer (BD Biosciences), avoiding doublets
and cell debris. After sorting, plates were immediately sealed, spun down,
frozen on dry ice and stored at −80°C.
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Cell culture, fixation and FISH
Human ES cells were dissociated to single cells using Accutase (Life
Technologies, A11105-01), and 30,000 cells were plated per well of 96-well
imaging plate coated with Geltrex (Gibco) in mTeSR1 media. The culture
media were changed daily and fixed on the third day when cells were ∼90%
confluent. Before fixing they were stained with 2uM CFSE for 20 min in the
incubator. The cells were fixed in 4% formaldehyde solution while covered
with aluminum foil for 30 min at room temperature and then dehydrated in
50%, 70% and 100% ethanol for 2 min each concentration. The plates were
stored in 100% ethanol in a −20°C chest freezer.
Following fixation, expression levels of three different mRNA transcripts
were measured in situ using RNA-FISH probes (Thermo Fisher Scientific)
as previously described (Shalek et al., 2013). Briefly, the ViewRNA ISH
Cell Assay Kit (Invitrogen) was performed to stain cells according to the
manufacturer’s recommendations. Following staining, cells were imaged on
an Olympus IX83 inverted microscope using 405 nm excitation for the
DAPI stain and 647 nm excitation for the RNA-FISH probes. To quantify
RNA expression, single cells were segmented using CellProfiler, and their
total probe content was summed over the volume of the cell. Integrated
probe intensity box plots were generated to confirm qualitative agreement
between RNA-FISH and scRNA-seq.
scRNA-seq
Following sorting, 96-well plates of single cells were whole-transcriptome
amplified using a Smart-Seq2-based approach, as previously described
(Trombetta et al., 2014). Cell lysates were first cleaned with 2.2× volume
AMPure XP SPRI beads (Beckman Coulter). Reverse transcription and PCR
were then performed on the samples. Following whole-transcriptome
amplification, PCR products were cleaned with 0.9× volume SPRI beads and
eluted into 20 μl of water. Concentration of cDNA in the resulting solutionwas
determined using a Qubit 3.0 Fluorimeter (Thermo Fisher Scientific) and
analyzed using a high sensitivity DNA chip for BioAnalyzer (Agilent
Technologies). Whole-transcriptome amplification products were diluted to a
concentration of 0.1 to 0.4 ng/μl and tagmented and amplified using Nextera
XTDNASample preparation reagents (Illumina). Tagmentationwas performed
according to the manufacturer’s instructions, modified to use one quarter of the
recommended volume of reagents, extended tagmentation time to 10 min and
extended PCR time to 60 s. PCR primers were ordered from Integrated DNA
Technologies. Primer sequences: 3′ SMART CDS Primer IIA: 5′ AAGCAG-
TGGTATCAACGCAGAGTACT(30)VN; SMARTer II A oligonucleotide: 5′
AAGCAGTGGTATCAACGCAGAGTACATrGrGrG; IS PCR primer: 5′
AAGCAGTGGTATCAACGCAGAGT. Nextera products were then cleaned
with 0.9× volume of SPRI beads and eluted inwater. The librarywas quantified
using Qubit and analyzed using a high-sensitivity DNA chip. The library was
diluted to 2.2 pM and sequenced on a NextSeq 500 (Illumina).
Processing of scRNA-seq data
RNA-seq reads were first trimmed using Trimmomatic (Bolger et al., 2014).
Trimmed reads were aligned to the RefSeq hg38 genome and transcriptome
(GRCh38.2) using Bowtie2 (Langmead and Salzberg, 2012) and TopHat
(Trapnell et al., 2009), respectively. The resulting transcriptome alignments
were processed using RSEM to estimate the abundance of RefSeq
transcripts (Li and Dewey, 2011), in transcripts per million reads mapped
(TPM). All cells with fewer than 2000 detectable transcripts (TPM>1) were
removed from further analysis. Expression levels for gene i in sample j were
quantified as Ei,j=log(TPMi,j+1). Relative expression level for gene i was
computed within each subpopulation S as Eri;Sj ¼ Ei;Sj –E^i;S , where
E^i;S ¼ average½Ei;S1...Sn or the mean expression of that gene across all
cells within subpopulation S.
Unsupervised dimensionality reduction
To visualize cells in 2-dimensional space, we first performed principal
component analysis (PCA) using the Seurat R package version 2.0 as
previously described (Satija et al., 2015) using highly variable genes of
mean expression ≥1. We then determined the statistically significant
principal components by calculating 1000 random permutations of 1% of
genes in the data.We used all significant principal components (P<10−10) as
input to non-linear dimensionality reduction via t-distributed stochastic
neighbor embedding (t-SNE).
Classification of cells into ES cells, endoderm, mesoderm and
ectoderm
We calculated ES cell, endoderm (dEN), mesoderm (dME) and ectoderm
(dEC) scores for all cells by using the AddModuleScore function in Seurat
with default parameters for the top 50 most uniquely expressed markers for
the ES cell, dEN, dME and dEC purified populations (Gifford et al., 2013)
that were also present in the scRNA-seq data. Uniqueness was defined as in
previous studies (Tsankov et al., 2015a). Cells were then classified into one of
four cell types, based on the maximal ES cell, dEN, dME or dEC score. We
obtained in silico-sorted populations of ES cells by filtering out all cells
collected at day 0 that had an ES cell score≥max[dEN score, dME score, dEC
score]. We defined dEN, dME and dEC in silico-sorted populations similarly.
Hierarchical clustering of sorted samples
Relative expression values for all genes was averaged across all ES or dME
cells for the defined subpopulations (WT ES cells, 3AKO, DKO, DNMT1−/−
day 0, 2, 8). The mean relative expression values were then clustered using
hierarchical clustering, average linkage, and 1−Pearson correlation coefficient
(r) of all non-zero values as a distance metric.
Inter- and intra-sample cell-cell distance
Inter-sample cell-cell distance was computed by comparing all pairs of cells
between two samples, using 1−Pearson correlation coefficient (r) of all non-
zero values as a distance metric. Intra-sample cell-cell distance was
computed by comparing all pairs of cells within a sample using the same
distance metric. Cells in each comparison were in silico sorted to contain
only ES (Figs 1, 2, 3 and 5), dME or dEC cells (Fig. 4). Before computing
the distance, all cells were quantile normalized to control for the total
number of transcripts detected per cell. The same approach was applied for
other distance metrics (Euclidean, Manhattan and 1-Spearman correlation).
Gene expression dispersion analysis
To assay the level of transcriptional variation per gene, we first quantile
normalized TPMs for all cells within each sample population and then
computed the dispersion or log(variance/mean) forall genes.Wealso performed
quantile normalization before computing other measures of transcript variation.
Normalized methylation entropy analysis
To compare the variability of methylation levels at the individual CpG and
read level, we used ‘informMe’, an information-theoretic approach that uses
the Ising model of statistical physics to generate mean methylation levels
and normalized methylation entropy per CpG. We ran informME for WT,
3AKO and DKO data, for all CpGs located on chromosomes 21 and 22, and
used R to plot the respective levels of mean methylation level (MML) and
normalized methylation entropy (NME).
Three-way differential expression analysis
Differential expression was tested across all possible pairwise comparisons
(100, 101, 110, 011, 010 and 001) of three samples, where 1 or 0 indicates
high or low expression for the respective sample (e.g. WT, 3AKO and DKO
ES cells). To measure differential expression, we used the likelihood-ratio test
for single-cell gene expression (McDavid et al., 2013) as implemented in the
Seurat R package, requiring a P value≤10−8 and 1.22-fold change. For ease of
visualization, differentially expressed genes were then combined into gene
sets representing all possible three-way comparisons (100, 101, 110, 011, 010
and 001) and gene expression was row normalized across cells. Genes were
only included in one gene set that had the highest P value in differential
expression. The same analysis was performed to compare WT, 3AKO and
DKO dME/dEC cells and day 0, 2 and 8 DNMT1-depleted ES cells.
Genomic region enrichment analysis
We assessed the significance of overlap of any gene set against a number of
predefined genomic regions that can be mapped to their nearest downstream
gene. Significance was calculated using the hypergeometric distribution
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with Bonferroni correction for multiple hypotheses testing. The resulting
P value was −log() transformed and displayed for a number of genomic
regions (rows), including CpG density features, epigenetic, and TF binding
data collected in matching WT, ES, or dME cells (Gifford et al., 2013;
Tsankov et al., 2015b). This analysis was performed for gene sets predefined
using the three-way differential expression analysis as well as for high and
low dispersion set of genes for all samples.
Gene set enrichment analysis
Gene sets enrichment analysis (http://software.broadinstitute.org/gsea/) was
performed on defined gene sets above selecting only for common pathways
from the REACTOME database (http://www.reactome.org/).
Cell cycle differential expressed genes and phase classification
To show differentially expressed cell cycle annotated genes, we performed
the three-way differential expression analysis as described above solely for
genes related to the cell cycle (Whitfield et al., 2002; Kanehisa and Goto,
2000). We used a less stringent threshold for displaying cell cycle annotated
differentially expressed genes of P value≤10−4. For visualization, cells
(columns) within each sample were ordered according to progress in the cell
cycle, as previously described (Kowalczyk et al., 2015), starting with M/G1
cells on the left and ending with G2/M cells on the right. Expression values
were averaged using a 20-cell window.
To assign cells according to cell cycle phase, we used a similar approach to
that previously described (Tirosh et al., 2016). Briefly, we defined cell cycle
phase-specific markers for G1/S, S, G2/M for ES, dME and dEC cells
separately, keeping only genes in each predefined cell cycle phase gene set
(Whitfield et al., 2002) if they had a correlation r≥0.3 with the average gene
set expression. The most predictive markers for M/G1 phase cells were key
markers with a lowexpression in the other phases (G1/S, S, G2/M). Cells were
quantile normalized in expression, which preserves the order in expression
levels between genes within a cell. We then measured the cell cycle phase
score of each cell as the average relative expression Eri,Sj of the selected cell
cycle phase markers, where the M/G1 score was multiplied by −1, as it
consisted of lowly expressed cell cycle markers for other phases. We used
these scores to assign single cells to phases of the cell cycle, according to their
maximal score for the four cell cycle phases.
Cell cycle phase-specific expression
Phase-specific expression for each gene i that peaked in expression in phase j
(for example j=M/G1) was defined as Ei;j ¼ Ei;M=G1 ¼ E^i;M=G1
average½E^i;G1=S ; E^i;S ; E^i;G2=M , where E^i;j represents the average expression
of gene in all cells classified as phase j of the cell cycle for a given sorted
population of cells. This analysis was repeated for all genes that peaked in
expression in one of four possible phases of the cell cycle (M/G1, G1/S, S and
G2/M). Bar plots for cell cycle phase-specific expression in different cell
types display the mean phase specific expression for a given gene set (all
genes, cell cycle genes or differentially expressed cell cycle genes); error bars
represent one standard deviation.
Acknowledgements
We thank all members of the Meissner and Shalek laboratories for their support and
feedback.
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: A.M.T., A.K.S., A.M.; Methodology:M.H.W., V.A., A.M.T., A.A., J.C.,
S.J.A., B.E.M., R.S.D., A.K.S., A.M.; Validation: M.H.W., V.A., A.M.T., S.J.A., B.E.M.,
R.S.D., A.K.S., A.M.; Formal analysis: A.M.T., J.C., M.H.W., S.J.A.; Investigation:
A.M.T., A.K.S., A.M.; Resources:M.H.W., V.A., A.A., J.C., Z.D.S., T.S.M.; Data curation:
A.M.T., A.A., J.C.; Writing - original draft: A.M.T., M.H.W., A.K.S., A.M.; Writing - review
& editing: A.M.T., J.C., A.K.S, A.M.; Visualization: A.M.T.; Supervision: A.K.S., A.M.;
Project administration: A.K.S., A.M.; Funding acquisition: A.K.S., A.M.
Funding
A.M.T. is supported, in part, by the Icahn School of Medicine at Mount Sinai internal
seed funding and the Chan Zuckerberg Initiative (CZI). A.M. was supported by the
National Institutes of Health (NIH) (P01GM099117 and 1DP3K111898) and theMax
Planck Society. A.K.S. was supported, in part, by the Searle Scholars Program, the
Beckman Young Investigator Program, the Pew-Stewart Scholars Program for
Cancer Research, a Sloan Fellowship in Chemistry and the NIH (2RM1HG006193).
Deposited in PMC for release after 12 months.
Data availability
All data have been deposited in GEO under accession number GSE134483.
Supplementary information
Supplementary information available online at
http://dev.biologists.org/lookup/doi/10.1242/dev.174722.supplemental
References
Bolger, A. M., Lohse, M. and Usadel, B. (2014). Trimmomatic: a flexible trimmer
for Illumina sequence data. Bioinformatics 30, 2114 -2120. doi:10.1093/
bioinformatics/btu170
Chan, M. M., Smith, Z. D., Grosswendt, S., Kretzmer, H., Norman, T. M.,
Adamson, B., Jost, M., Quinn, J. J., Yang, D. and Jones, M. G. (2019).
Molecular recording of mammalian embryogenesis. Nature 570, 77-82. doi:10.
1038/s41586-019-1184-5
Gifford, C. A., Ziller, M. J., Gu, H., Trapnell, C., Donaghey, J., Tsankov, A.,
Shalek, A. K., Kelley, D. R., Shishkin, A. A., Issner, R. et al. (2013).
Transcriptional and epigenetic dynamics during specification of human embryonic
stem cells. Cell 153, 1149-1163. doi:10.1016/j.cell.2013.04.037
Haghverdi, L., Buettner, F. and Theis, F. J. (2015). Diffusion maps for high-
dimensional single-cell analysis of differentiation data. Bioinformatics 31,
2989-2998. doi:10.1093/bioinformatics/btv325
Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Langmead, B.,
Mcdonald, O. G., Wen, B., Wu, H., Liu, Y., Diep, D. et al. (2011). Increased
methylation variation in epigenetic domains across cancer types. Nat. Genet. 43,
768. doi:10.1038/ng.865
Heitzler, P. and Simpson, P. (1991). The choice of cell fate in the epidermis of
Drosophila. Cell 64, 1083-1092. doi:10.1016/0092-8674(91)90263-X
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke,
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Figure S1 supporting Figure 1: Increased cellular variation in DNMT3A and 
DNMT3A/3B knockout ES cells 
A. Inter-sample (top) and intra-sample (bottom) density distribution of pairwise 
cell-cell distances (1-Pearson correlation coefficient) for in silico sorted 
undifferentiated WT (n = 162), 3AKO (n = 74), and DKO cells (n = 74). 
B. Inter-sample (top) and intra-sample (bottom) density distribution of pairwise 
cell-cell distances (1-Pearson correlation coefficient) for only the highest 
quality cells (number of genes detected > 7,000) for wildtype (n = 149), 
3AKO (n = 56), and DKO (n = 58) ES cells. 
C. Intra-sample density distribution of pairwise cell-cell distances in in silico 
sorted undifferentiated WT (n = 162), 3AKO (n = 74), and DKO cells (n = 
74) using four different distances: 1- Pearson correlation coefficient (top
left), 1- Spearman rank correlation (bottom left), Euclidean L2 norm (top 
right) and Manhattan L1 norm (bottom right). 










































Figure S2 supporting Figure 2: Relationship between DNA methylation level, 
mean methylation entropy and transcript variation in DNMT3A and 
DNMT3A/3B knockouts  
A. Box plots of gene expression standard deviation computed across all cells 
(left) and only among cells with detectable gene expression (σ, right) for 
gene sets composing of all genes, ES cell markers, and WT low dispersion 
genes for WT, 3AKO, and DKO ES cells. Boxes display the interquartile 
range while the bold line shows the median and whiskers extend to the most 
extreme data point that is no more than 1.5 times the interquartile range. 
B. Violin plots of log gene expression level, log(TPM+1), for 50 selected genes 
that have a difference in dispersion greater than 1.5 between two samples, 
where the samples being compared are annotated using column headers 
on the top and the overall number of genes present in each category is 
shown in parentheses. The change in average expression relative to 
dispersion is annotated along rows on the left. The majority of genes (>90%) 
that increase in dispersion also increase in average expression. TPM = 
transcripts per million fragments mapped. 
C. Representative images of RNA FISH experiment showing staining for DAPI 
(blue) and red fluorescent probes targeting ZFP42 (left), MAP4K4 (middle) 
and RAD51 (right) in WT (top) and 3AKO (bottom) ES cells. Cell 
segmentation is shown using white outlines. White bar in bottom right corner 
of each panel indicates a distance of 10 microns. 
D. Genomic enrichment analysis for high (left) and low (right) transcript 
dispersion genes in WT, 3AKO, and DKO sorted ES cells overlapped with 
the promoter epigenetic state of matching WT ES cells (Gifford et al., 2013, 
Tsankov et al., 2015b). We observe a high enrichment of highly methylated 
promoter regions at low dispersion WT genes but this enrichment 
decreases for low dispersion 3AKO and DKO genes. 
E. Boxplot of the promoter mean normalized methylation entropy (NME; left) 
and mean methylation level (MML; right) measured for WT, 3AKO, and DKO 
ES cell WGBS data for all chromosome 21 and 22 promoters using the 
approach in (Jenkinson et al., 2017). Boxes display the interquartile range 
while the bold line shows the median and whiskers extend to the most 
extreme data point that is no more than 1.5 times the interquartile range. 
F. Correlation scatter plots of transcriptional variation measured in terms of 
dispersion (top) and standard deviation (σ) of detectable transcripts 
(bottom) versus promoter mean normalized methylation entropy for all WT 
(left), 3AKO (middle) and DKO (right) promoters on chromosomes 21 and 
22.





















Figure S3 supporting Figure 3: Widespread transcriptional repression and 
changes in cell cycle gene expression in DNMT3A and DNMT3A/B knockout 
ES cells 
A. Browser tracks display methylation levels for WT and DKO cells over a 28kb 
region on chromosome 5. Grey bars highlight DKO-specific differentially 
methylated regions (DMRs; difference > 0.6, P < 0.01). An ES cell super-
enhancer (Hnisz et al., 2013) is highlighted in purple with ENCODE ChIP-
seq data for H3K27ac and H3K4me1 in H1 ES cells displayed below. CpGs 
located within the super-enhancer region lose substantial methylation upon 
loss of DNMT3A and 3B. 
B. Differentially expressed cell cycle annotated genes (right; rows) for sorted 
population of WT, 3AKO, and DKO ES cells (columns) ordered by progress 
in the cell cycle. Gene sets (left) are defined in Fig. 2A. 
C. Fraction of cells in M/G1, G1/S, S, and G2/M phase for in silico sorted WT, 
3AKO, and DKO ES cell populations. 










































Figure S4 supporting Figure 4:  Transcriptional misregulation in DNMT3A/B 
knockout cells following mesoderm differentiation 
A. Violin plot of mesoderm (left) and ectoderm (right) scores for WT, 3AKO, 
and DKO cells following 5 days of differentiation towards mesoderm and 
ectoderm, respectively. Each dot represents a cell. 
B. Distribution of ZFP42 expression for in silico sorted WT, 3AKO, and DKO 
ES (left), mesoderm (middle), and ectoderm (right) cells. 
C. Genomic enrichment analysis for gene sets (columns) defined in Figure 4F 
against DNA methylation, CpG density features, and chromatin data 
collected in matching WT dME cells (Gifford et al., 2013, Tsankov et al., 
2015b). DMR = differentially methylated region; K = lysine histone 3; me3 = 
tri-methylation; ac = acetylation; me1 = mono-methylation. 
D. Genomic enrichment analysis for gene sets (columns) defined in Figure 4G 
against DNA methylation, CpG density features, and chromatin data 
collected in matching WT dEC cells. 
E. Violin plots of log(TPM+1) gene expression for key developmental and 
oncogenic TFs misregulated in dEC 3AKO and/or DKO mutants. TFs 
displayed were either downregulated in DKO (top row; gene set 110), 
upregulated in 3AKO (middle row; gene sets 011 & 010), or upregulated in 
DKO (bottom row; gene set 001). 
F. Violin plot of ES cell scores for WT, 3AKO, and DKO cells following 5 days 
of differentiation towards ectoderm. DKO dEC sample has a higher median 
and standard deviation in ES cell scores. 
G. Differentially expressed cell cycle annotated genes (right; rows) for sorted 
population of WT, 3AKO, and DKO dME cells (columns) ordered by 
progress in the cell cycle. Gene sets (left) are defined in panel Figure 4F. 
H. Fraction of cells in M/G1, G1/S, S, and G2/M phase for sorted WT, 3AKO, 
and DKO dME (left) and dEC (right) cell populations. 
I. Distribution of cell cycle phase specific expression for sorted WT, 3AKO, 
and DKO dME (left) and dEC (right) cells considering all genes, cell cycle 
annotated genes, and differentially expressed cell cycle annotated genes. 
Error bars indicate one standard deviation. 










































Figure S5 supporting Figure 5: Loss of DNMT1 triggers increased transcript 
variation and differentiation 
A. Genomic enrichment analysis for high (left) and low (right) transcript 
dispersion genes at day 0, 2, and 8 sorted ES cells following DOX treatment 
overlapped with the promoter epigenetic state of WT HUES64 ES cells 
(Gifford et al., 2013, Tsankov et al., 2015b). We observe a high enrichment 
of highly methylated promoter regions at day 0 low dispersion genes but 
this enrichment gradually decreases for low dispersion day 2 and day 8 
genes while the enrichment at H3K9me3 promoters remains. 
B. Fraction of cells in M/G1, G1/S, S, and G2/M phase for in silico sorted ES 
cells at day 0, 2, and 8. 
C. Distribution of cell cycle phase specific expression for day 0, 2, and 8 sorted 
ES cells considering all genes, known cell cycle associated genes, and 
known, differentially expressed cell cycle annotated genes. Error bars 
indicate one standard deviation. 
Table S1: Differentially expressed genes in wildtype (WT), DNMT3A-/- (3AKO) 
and DNMT3A/B-/- (DKO) ES cells 
Three-way differentially expressed genes (rows in spreadsheet “Markers”) for 
sorted population of WT, 3AKO, and DKO ES cells, displayed in Fig. 2A. Genes 
are separated into 6 clusters (100, 101, 110, 011, 010, and 001), where 1 or 0 
indicates high or low expression for the respective condition (order: WT, 3AKO, 
DKO). Spreadsheets “100” to “001” contain functional enrichment analysis for 
genes in each cluster from spreadsheet “Markers” against the REACTOME 
database. 
Click here to Download Table S1
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